Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Pilot Study With TMX 101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

NCT01731652 is registered in ClinicalTrials.gov with Telormedix SA as lead sponsor.

NCT NCT01731652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01731652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Pilot Study With TMX 101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Lead sponsor
Telormedix SA
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
October 31, 2014
Enrollment
12 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma in situ, non muscle invasive bladder cancer